Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Alterity Therapeutics Ltd. ( (AU:ATH) ) just unveiled an announcement.
Alterity Therapeutics Limited has announced the issuance of over 1.1 billion fully paid ordinary shares without disclosure under Part 6D.2 of the Corporations Act. The company has complied with all relevant regulations and states there is no ‘excluded information’ to disclose, indicating transparency and regulatory adherence in its operations.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Limited operates within the biotechnology industry, focusing on developing therapeutic solutions, particularly in the field of neurodegenerative diseases. The company is publicly traded on both the Australian Securities Exchange (ASX) and NASDAQ, under the ticker symbols ATH and ATHE, respectively.
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $38.38M
Learn more about ATH stock on TipRanks’ Stock Analysis page.
